XML 32 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Cover - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Mar. 18, 2022
Jun. 30, 2021
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2021    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-04321    
Entity Registrant Name CONTEXT THERAPEUTICS INC.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 86-3738787    
Entity Address, Address Line One 2001 Market Street    
Entity Address, Address Line Two Suite 3915    
Entity Address, Address Line Three Unit #15    
Entity Address, City or Town Philadelphia    
Entity Address, State or Province PA    
Entity Address, Postal Zip Code 19103    
City Area Code 267    
Local Phone Number 225-7416    
Title of 12(b) Security Common Stock, par value $0.001 per share    
Trading Symbol CNTX    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Entity Ex Transition Period false    
ICFR Auditor Attestation Flag    
Entity Shell Company false    
Entity Common Stock, Shares Outstanding   15,966,053  
Documents Incorporated by Reference Portions of the registrant’s definitive Proxy Statement for its 2022 Annual Meeting of Stockholders to be filed with the Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K are incorporated by reference in Part III, Items 10-14 of this Annual Report on Form 10-K.    
Entity Central Index Key 0001842952    
Amendment Flag false    
Document Fiscal Year Focus 2021    
Document Fiscal Period Focus FY    
Entity Public Float     $ 0